Evergreen Capital Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Evergreen Capital Management's SMMT Position: Q3 2026 in Review
Evergreen Capital Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 13,514 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #1330 among its holdings.
298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Evergreen Capital Management held 13,514 shares of Summit Therapeutics worth $229K as of Q3 2026.
- Summit Therapeutics was a new Evergreen Capital Management position in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of Evergreen Capital Management's portfolio in Q3 2026, its #1330 holding.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Evergreen Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.